|
Feb 13
|
Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update
|
|
Feb 12
|
What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'
|
|
Jan 14
|
Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?
|
|
Jan 10
|
Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?
|
|
Jan 10
|
Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long
|
|
Jan 10
|
Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable
|